LAVA Therapeutics NV (LVTX)

$1.46 -$0.43 (-22.51%) 4:37 PM 12/10/24
NASDAQ | $USD | Biotechnology

Stock Data

  • Market Cap

    $46.55M

  • Day's Range

    $1.47 - $1.92

  • Volume

    106,077

  • 52 Week Low / High

    $1.35 - $4.21

  • PE Ratio

    -

  • PEG Ratio

    -

  • Dividend Frequency

    -

LVTX's Dividend
-
Amount
-
Dividend Yield
-
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
2
Strong Buy
2
Buy
0
Hold
0
Sell
0
Strong Sell
$6.80
Target Price

Company News

  • Why Is Cancer Focused LAVA Therapeutics Nano Cap Stock Trading Higher Today? — Jan 25th, 2024

    LAVA Therapeutics NV (NASDAQ:LVTX) has entered into a clinical trial collaboration and supply agreement with Merck & Co Inc (NYSE:MRK) to evaluate its anti-PD-1 therapy Keytruda (pembrolizumab) in combination with LAVA-1207 in patients with therapy refractory metastatic castration-resistan...

Similar Stocks

No similar stocks found.

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free